Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery.
Uncontrolled interactions of gene vectors and drug carriers in and with an in vivo environment pose serious limitations to their applicability. In order to reduce such interactions we have designed, synthesized and applied novel copolymers of poly(ethylene glycol) and reactive linkers which are derivatized with anionic peptides after copolymerization. The anionic copolymer derivatives are used to coat positively charged nonviral gene vectors by electrostatic interactions. The copolymer coat confers to polyelectrolyte colloids of DNA and polycations steric stabilization in their minimal size and prevents salt- and serum albumin-induced aggregation. Furthermore, complement activation and the interaction with serum proteins are drastically reduced or abolished in contrast to unprotected DNA complexes. The designed vectors are compatible with the intracellular steps of gene delivery and can even enhance transfection efficiency as demonstrated with various adherent and nonadherent cell lines in culture. The synthetic concept is amenable to the principles of combinatorial chemistry and the copolymeric products may be applicable beyond gene delivery in targeted drug delivery. Gene Therapy (2000) 7, 1183-1192.
Finsinger
D
D
Institute of Experimental Oncology, TU München, Munich, Germany.
Remy
J S
JS
Erbacher
P
P
Koch
C
C
Plank
C
C
D002478:Cells, Cultured; D003102:Colloids / Q000378:metabolism; D003165:Complement System Proteins / Q000276:immunology; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000138:chemical synthesis* / Q000737:chemistry / Q000276:immunology; D006801:Humans; D009895:Opsonin Proteins / Q000378:metabolism; D010316:Particle Size; D011092:Polyethylene Glycols / Q000138:chemical synthesis* / Q000737:chemistry; D014162:Transfection
D003102:Colloids; D009895:Opsonin Proteins; D011092:Polyethylene Glycols; D003165:Complement System Proteins